Evra
Authorisation EU/1/02/223/003 · Gedeon Richter Plc
- Licence holder
- Gedeon Richter Plc (all products →)
- Active substances
- Norelgestromin, Ethinylestradiol
- Dosage form
- Transdermal patch
- First authorised
- 22/08/2002
- Prescription status
- Product subject to prescription which may be renewed (B)
- Supply
- Supply through pharmacies only
- Legal basis
- Full application (Article 8(3) of Directive No 2001/83/EC)
Norelgestromin: supply and approvals
3 authorised products on the HPRA list contain Norelgestromin. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 20 Nov 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 20 Nov 2026)
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 20 Nov 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
Ethinylestradiol: supply and approvals
37 authorised products on the HPRA list contain Ethinylestradiol. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 20 Nov 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 20 Nov 2026)
- Germany (BfArM)
- 3 supply notices, e.g. Novial (31 Mar 2023 to 31 Dec 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
About this licence
Centralised EU authorisation. This product holds an EU-wide marketing authorisation granted by the European Commission after assessment by the European Medicines Agency, valid in every EU country. Its EU product number is 223. It has been authorised for 24 years (since 22 August 2002). The HPRA list does not say whether it is on sale.
Other medicines with Norelgestromin in Ireland
2 other products on the HPRA list contain Norelgestromin, from 1 licence holder; 0 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
| Medicine | Licence holder | Licence | Status |
|---|---|---|---|
| Evra | Gedeon Richter Plc | Centralised EU authorisation | Not stated |
| Evra 203 micrograms/24 hours + 33.9 micrograms/24 hours transdermal patch | Gedeon Richter Plc | Centralised EU authorisation | Not stated |
Other medicines with Ethinylestradiol in Ireland
38 other products on the HPRA list contain Ethinylestradiol, from 11 licence holders; 19 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
| Medicine | Licence holder | Licence | Status |
|---|---|---|---|
| Cilique 250/35 microgram tablets | Gedeon Richter Plc | National authorisation (PA) | Marketed |
| Elvina 0.03mg/3mg film-coated tablets | Gedeon Richter Plc | National authorisation (PA) | Marketed |
| Elvinette 0.02mg/3mg film-coated tablets | Gedeon Richter Plc | National authorisation (PA) | Marketed |
| Freedo 0.03mg/3mg film-coated tablets | Rowex Limited, | National authorisation (PA) | Marketed |
| Freedonel 0.02 mg/3 mg film-coated tablets | Rowex Limited, | National authorisation (PA) | Marketed |
| Leonore 100 micrograms/20 micrograms coated tablets | Rowex Limited, | National authorisation (PA) | Marketed |
| Logynon Tablets | Bayer Limited | National authorisation (PA) | Marketed |
| Logynon Tablets | Bayer Limited | National authorisation (PA) | Marketed |
| Logynon Tablets | Bayer Limited | National authorisation (PA) | Marketed |
| Marviol 150/30 microgram Tablets | Organon Pharma (Ireland) Limited | National authorisation (PA) | Marketed |
| Mercilon 150/20 microgram Tablets | Organon Pharma (Ireland) Limited | National authorisation (PA) | Marketed |
| Microlite 100 microgram/20 microgram coated tablets | Bayer Limited | National authorisation (PA) | Marketed |
The licence holder
Gedeon Richter Plc holds 48 products on the HPRA list, with 22 different active substances; 13 of the products are marked as marketed.
This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.
How this page is built
The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.
- HPRA Authorised Medicines List (open data) ↗ Licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status for this product
This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 21 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.